Subscribe
Sign in
Home
Notes
Archive
About
Transcripta Bio collaborates with Microsoft Research to Advance AI-Driven Disease-Gene Discovery
Palo Alto, CA – May 28, 2025 - Transcripta Bio today announced a research collaboration with Microsoft Research to accelerate the discovery of…
May 28
•
Transcripta Bio
2
Share this post
Transcripta Bio
Transcripta Bio collaborates with Microsoft Research to Advance AI-Driven Disease-Gene Discovery
Copy link
Facebook
Email
Notes
More
Transcripta Bio's new visual brand language
Introducing Eigenfish: our new brand imagery
May 6
•
Transcripta Bio
and
Clayton Mellina
1
Share this post
Transcripta Bio
Transcripta Bio's new visual brand language
Copy link
Facebook
Email
Notes
More
April 2025
Mastering the transcriptome with artificial intelligence
Chemo-transcriptomics at scale
Apr 16
•
Transcripta Bio
2
Share this post
Transcripta Bio
Mastering the transcriptome with artificial intelligence
Copy link
Facebook
Email
Notes
More
Transcripta Bio Named to the TIME100 Most Influential Companies of 2024
Palo Alto, Calif., May 30, 2024 – Transcripta Bio, a platform drug development biotechnology company that is revolutionizing discovering and developing…
Apr 16
•
Transcripta Bio
1
Share this post
Transcripta Bio
Transcripta Bio Named to the TIME100 Most Influential Companies of 2024
Copy link
Facebook
Email
Notes
More
Unveiling Transcripta Bio
Today we are unveiling Transcripta Bio.
Apr 16
•
Transcripta Bio
1
Share this post
Transcripta Bio
Unveiling Transcripta Bio
Copy link
Facebook
Email
Notes
More
Rarebase Names Chris Moxham as Chief Executive Officer
See full press release on PR Newswire.
Apr 16
•
Transcripta Bio
1
Share this post
Transcripta Bio
Rarebase Names Chris Moxham as Chief Executive Officer
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
